These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35972746)

  • 21. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment.
    Tungsanga K; Sriboonlue P; Futrakul P; Yachantha C; Tosukhowong P
    Urol Res; 2005 Feb; 33(1):65-9. PubMed ID: 15565439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Citrate and renal calculi: an update.
    Pak CY
    Miner Electrolyte Metab; 1994; 20(6):371-7. PubMed ID: 7783699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term treatment of calcium nephrolithiasis with potassium citrate.
    Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
    J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
    Ruml LA; Gonzalez G; Taylor R; Wuermser LA; Pak CY
    Am J Ther; 1999 Jan; 6(1):45-50. PubMed ID: 10423646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alkali absorption and citrate excretion in calcium nephrolithiasis.
    Sakhaee K; Williams RH; Oh MS; Padalino P; Adams-Huet B; Whitson P; Pak CY
    J Bone Miner Res; 1993 Jul; 8(7):789-94. PubMed ID: 8352061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
    Preminger GM; Sakhaee K; Skurla C; Pak CY
    J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Citrate-based dietary alkali supplements available in Germany: an overview.
    Storz MA; Ronco AL
    J Pharm Health Care Sci; 2024 May; 10(1):22. PubMed ID: 38730472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of orange juice consumption on urinary stone risk factors.
    Wabner CL; Pak CY
    J Urol; 1993 Jun; 149(6):1405-8. PubMed ID: 8501777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
    Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
    Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potassium-sodium citrate prevents the development of renal microcalculi into symptomatic stones in calcium stone-forming patients.
    Unno R; Taguchi K; Okada A; Ando R; Hamamoto S; Kubota Y; Zuo L; Tozawa K; Kohri K; Yasui T
    Int J Urol; 2017 Jan; 24(1):75-81. PubMed ID: 27747937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.
    Sakhaee K; Nicar M; Hill K; Pak CY
    Kidney Int; 1983 Sep; 24(3):348-52. PubMed ID: 6645208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation.
    Robinson MR; Leitao VA; Haleblian GE; Scales CD; Chandrashekar A; Pierre SA; Preminger GM
    J Urol; 2009 Mar; 181(3):1145-50. PubMed ID: 19152932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.
    Ettinger B; Pak CY; Citron JT; Thomas C; Adams-Huet B; Vangessel A
    J Urol; 1997 Dec; 158(6):2069-73. PubMed ID: 9366314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physicochemical action of potassium-magnesium citrate in nephrolithiasis.
    Pak CY; Koenig K; Khan R; Haynes S; Padalino P
    J Bone Miner Res; 1992 Mar; 7(3):281-5. PubMed ID: 1585829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
    Pak CY; Peterson R
    Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the association of potassium citrate and agropyrum repens in renal stone treatment: results of a prospective randomized comparison with potassium citrate.
    Brardi S; Imperiali P; Cevenini G; Verdacchi T; Ponchietti R
    Arch Ital Urol Androl; 2012 Jun; 84(2):61-7. PubMed ID: 22908773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.
    Doizi S; Poindexter JR; Pearle MS; Blanco F; Moe OW; Sakhaee K; Maalouf NM
    J Urol; 2018 Dec; 200(6):1278-1284. PubMed ID: 30036516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Rocky Discontinuation of Diet Mountain Dew.
    Durland J; Schumann SO
    J Investig Med High Impact Case Rep; 2022; 10():23247096221114518. PubMed ID: 35866199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.